InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: Titan V post# 35559

Saturday, 07/30/2016 3:21:55 PM

Saturday, July 30, 2016 3:21:55 PM

Post# of 48316
This New York Times article probably sparked the boost in volume yesterday. After reading the full article I conclude that the results from Opdivo and Keytruda treatments are phenomenal and that Oncosec is right on track to address the shortcomings that are boggling scientists minds... a) turning non-responders into responders and b) reducing adverse affects of chemo and radiation. Oncosec can do both of these with electroporation and IL-12 in combo with keytruda. I can't wait for the combo data to come out and really get this ball rolling.